Kaleidoscope calms kids with cancer during needle pokes
NCT ID NCT07163104
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether using a kaleidoscope can reduce pain, anxiety, and fear in children aged 6-14 with cancer who are getting subcutaneous injections. The kaleidoscope is used as a distraction during the procedure. The study involves 72 children and compares their pain and fear levels using simple face scales.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- kaleidoscope
- What this could lead to
- If it works, this could give doctors a simple, safe, and cheap way to help children with cancer feel less pain and fear during injections.
- What could go wrong
- This is a small, early-stage study with only 72 children. The results may not apply to all children or settings, and a kaleidoscope may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 14 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 6-14 years, * Have an oncological diagnosis, * Have received at least one chemotherapy treatment before, * And whose parents are willing to participate in the study will be included in the study. Exclusion Criteria: * Children with any visual, auditory, verbal, or cognitive impairment, * Those in the terminal stages of their illness, * Those with a history of sedative, analgesic, or narcotic use within 24 hours of admission, * Those with a febrile illness or history of infection at the time of admission, * Those with a score of 2 or higher on the Wong-Baker Pain Scale independent of the procedure (during the pre-procedure assessment), * Those who do not complete the study will not be included in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Childhood cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zonguldak Bulent Ecevit University Training and Research Hospital
Zonguldak, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do children with cancer feel pain differently? study compares pain sensitivity and activity
- Can a phone app help childhood cancer survivors keep track of their health?
- Can a picture tool help kids with cancer say how they feel?
- Game-Based app aims to boost HPV vaccination in young cancer survivors
- Can young cancer survivors regain everyday independence?
- Can we predict growth problems in childhood cancer survivors?